general/monoclonal-antibodies-for-tumors

Sort: Quality Recent Views A-Z

Ofatumumab

Medication

general/monoclonal-antibodies-for-tumors

Ibritumomab tiuxetan

Radioimmunotherapy treatment

general/monoclonal-antibodies-for-tumors

Mapatumumab

Monoclonal antibody

general/monoclonal-antibodies-for-tumors

Olaratumab

Chemical compound

general/monoclonal-antibodies-for-tumors

Margetuximab

Monoclonal antibody

general/monoclonal-antibodies-for-tumors

Alemtuzumab

Medication

general/monoclonal-antibodies-for-tumors

Matuzumab

Monoclonal antibody

general/monoclonal-antibodies-for-tumors

Lintuzumab

Chemical compound

general/monoclonal-antibodies-for-tumors

Nimotuzumab

Chemical compound

general/monoclonal-antibodies-for-tumors

Mogamulizumab

Monoclonal antibody

general/monoclonal-antibodies-for-tumors

Bavituximab

Chemical compound

general/monoclonal-antibodies-for-tumors

Panitumumab

Pharmaceutical drug

general/monoclonal-antibodies-for-tumors

Indatuximab ravtansine

Chemical compound

general/monoclonal-antibodies-for-tumors

Elotuzumab

Pharmaceutical drug

general/monoclonal-antibodies-for-tumors

Minretumomab

Monoclonal antibody

general/monoclonal-antibodies-for-tumors

Catumaxomab

Monoclonal antibody

general/monoclonal-antibodies-for-tumors

Cetuximab

Pharmaceutical drug

general/monoclonal-antibodies-for-tumors